Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Related Posts NioCorp Acquires FEA Materials to Build US Scandium Supply Chain December 6, 2025 Copper Quest Closes $1,927,000 Private Placement December 6, 2025 Editor’s Picks: Silver Price Smashes All-time High, Nearly Hits US$60 December 6, 2025